Harry F. Hixson Jr., Director at NovaBay Pharmaceuticals, Inc. (NBY), bought 25,000 shares at $2.33 ($58K) on 2009-06-11, disclosed to the SEC on 2009-06-15.
Open-market purchase of $58k NBY by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| SQNM | BUY | 2011-11-16 | $210K | — | Filing → |
| ARNA | BUY | 2009-05-14 | $160K | — | Filing → |
| ARNA | BUY | 2008-06-10 | $94K | — | Filing → |